MACC1 and neoplasm: To evaluate the diagnostic value of circulating MACC1 transcripts in plasma, we compared newly diagnosed CRC patients with a primary tumor with or without synchronous metastases (n = 71) with tumor-free volunteers (n = 54) and calculated sensitivity and specificity with a fourfold table.